BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22167406)

  • 1. Antifungal PK/PD considerations in fungal pulmonary infections.
    Lepak AJ; Andes DR
    Semin Respir Crit Care Med; 2011 Dec; 32(6):783-94. PubMed ID: 22167406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetics and pharmacodynamics of antifungal drugs in children].
    Jullien V
    Arch Pediatr; 2011 May; 18 Suppl 1():S42-7. PubMed ID: 21596286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamic implications for use of antifungal agents.
    Lewis RE
    Curr Opin Pharmacol; 2007 Oct; 7(5):491-7. PubMed ID: 17616480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Aspergillus terreus infections: a clinical problem not yet resolved.
    Pastor FJ; Guarro J
    Int J Antimicrob Agents; 2014 Oct; 44(4):281-9. PubMed ID: 25190543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antifungal agents in the treatment of systemic infections: Relevance of mechanism of action, activity profile and resistances].
    Cuenca-Estrella M
    Rev Esp Quimioter; 2010 Dec; 23(4):169-76. PubMed ID: 21191554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current pharmacological concepts for wise use of echinocandins in the treatment of Candida infections in septic critically ill patients.
    Pea F
    Expert Rev Anti Infect Ther; 2013 Oct; 11(10):989-97. PubMed ID: 24093543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.
    Fera MT; La Camera E; De Sarro A
    Expert Rev Anti Infect Ther; 2009 Oct; 7(8):981-98. PubMed ID: 19803707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis.
    Chandrasekar PH; Cutright JL; Manavathu EK
    Clin Microbiol Infect; 2004 Oct; 10(10):925-8. PubMed ID: 15373889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances and challenges in the treatment of invasive fungal infections.
    Shao PL; Huang LM; Hsueh PR
    Int J Antimicrob Agents; 2007 Dec; 30(6):487-95. PubMed ID: 17961990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New therapeutical options for pulmonary fungal infections in non-neutropenic ICU-patients].
    Höhl R
    Mycoses; 2003; 46 Suppl 2():15-20. PubMed ID: 15055139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacology of antifungal agents in pediatrics: children are not small adults.
    Ramos-Martín V; O'Connor O; Hope W
    Curr Opin Pharmacol; 2015 Oct; 24():128-34. PubMed ID: 26366938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on echinocandin antifungals.
    Kauffman CA; Carver PL
    Semin Respir Crit Care Med; 2008 Apr; 29(2):211-9. PubMed ID: 18366002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics in the development of antifungal compounds.
    Andes D
    Curr Opin Investig Drugs; 2003 Aug; 4(8):991-8. PubMed ID: 14508883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal resistance in pathogenic fungi.
    Perea S; Patterson TF
    Clin Infect Dis; 2002 Nov; 35(9):1073-80. PubMed ID: 12384841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal drug resistance mechanisms in pathogenic fungi: from bench to bedside.
    Cuenca-Estrella M
    Clin Microbiol Infect; 2014 Jun; 20 Suppl 6():54-9. PubMed ID: 24372680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on antifungal drug resistance mechanisms of Aspergillus fumigatus.
    Chamilos G; Kontoyiannis DP
    Drug Resist Updat; 2005 Dec; 8(6):344-58. PubMed ID: 16488654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Choice and use of antifungal drugs].
    Dupont B
    Rev Prat; 2001 Apr; 51(7):752-7. PubMed ID: 11387672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in the treatment of systemic fungal infections.
    Walsh TJ
    Methods Find Exp Clin Pharmacol; 1987 Nov; 9(11):769-78. PubMed ID: 2834615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new in-vitro kinetic model to study the pharmacodynamics of antifungal agents: inhibition of the fungicidal activity of amphotericin B against Candida albicans by voriconazole.
    Lignell A; Johansson A; Löwdin E; Cars O; Sjölin J
    Clin Microbiol Infect; 2007 Jun; 13(6):613-9. PubMed ID: 17378925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal treatment in pediatric patients.
    Zaoutis TE; Benjamin DK; Steinbach WJ
    Drug Resist Updat; 2005 Aug; 8(4):235-45. PubMed ID: 16054422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.